Relatively recently, it has become apparent that a small but meaningful proportion of schizophrenic patients experience paniclike symptoms as a component of their condition. The full set of ...
SINGAPORE - A fast, non-invasive form of brain stimulation to reduce persistent negative symptoms such as social withdrawal and lack of motivation in patients with schizophrenia is being tested at ...
Using a multi-strain probiotic formulation, researchers conducted a double-blind, randomized, placebo-controlled trial aimed at improving psychiatric and cognitive symptoms, intestinal permeability, ...
The resulting new chemical entities bring new hope for patients worldwide with substantial unmet needs.” The company’s initial focus with brilaroxazine is on schizophrenia and associated ...
Brodmann area 22, namely the superior temporal gyrus, had a greater number of abnormally expressed genes in both diseases; moreover, genes that differentiated AD and schizophrenia patients from ...
Boehringer healthcare HCP Illustrative image Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, ...